Showing results (221-230 of 966) with videos related to
Sort By:
Pageof 97
Nature Reviews. Clinical Oncology|August 16, 2023
Targeting cancer with mRNA-lipid nanoparticles: key considerations and future prospectsEdo Kon, Nitay Ad-El, Inbal Hazan-Halevy, et al.Nature Reviews. Clinical Oncology|June 6, 2023
Emerging evidence for adapting radiotherapy to immunotherapyLorenzo Galluzzi, Molykutty J Aryankalayil, C Norman Coleman, et al.Nature Reviews. Clinical Oncology|September 19, 2023
Biomarkers for immunotherapy of hepatocellular carcinomaTim F Greten, Augusto Villanueva, Firouzeh Korangy, et al.Nature Reviews. Clinical Oncology|June 10, 2026
The future is not always uniform: rethinking radiotherapy through spatial fractionationFederico Iori, Slavisa Tubin, Waleed F Mourad, et al.Nature Reviews. Clinical Oncology|November 28, 2009
Hematology: first-line bortezomib benefits patients with multiple myelomaMeletios A Dimopoulos, Evangelos TerposNature Reviews. Clinical Oncology|July 1, 2026
Improving neoadjuvant and perioperative therapy in non-small-cell lung cancerYago Garitaonaindia, Heather A Wakelee, Martin Reck, et al.Nature Reviews. Clinical Oncology|November 12, 2021
Immunotherapies for hepatocellular carcinomaJosep M Llovet, Florian Castet, Mathias Heikenwalder, et al.Nature Reviews. Clinical Oncology|March 16, 2021
COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trialsAakash Desai, Justin F Gainor, Aparna Hegde, et al.Nature Reviews. Clinical Oncology|March 15, 2019
Paraneoplastic neurological syndromes in the era of immune-checkpoint inhibitorsFrancesc Graus, Josep DalmauNature Reviews. Clinical Oncology|February 24, 2019
Liquid biopsy and minimal residual disease - latest advances and implications for cureKlaus Pantel, Catherine Alix-PanabièresPageof 97